HI Semi... my view on Sepsis v Covid test is that Covid is getting Emergency Use priority and therefore was a shorter runway to commercial launch and therefore $$ in the bank for ADO... Sepsis by the look of it is not a test that is going to get emergency use as its not a Pandemic as such and cannot be transmitted.. that would mean a full program of Phase trials before launch which would mean ADO would require significant funds and a longer runway to commercial launch..
That said it is very sad as Roller points out that it is not really a focus given the death rate each year... even in first world countries..
I suspect once Covid tests are cemented in over the coming few months ADO will throw significant resources at fast tracking their Sepsis test for clinical trials.. it would not surprise me if they are once again ahead of schedule given they already have proof of concept..
- Forums
- ASX - By Stock
- ADO
- Urgent need for Sepsis tests by ADO
Urgent need for Sepsis tests by ADO, page-9
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.003(10.3%) |
Mkt cap ! $64.73M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.6¢ | $209.8K | 7.543M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 592714 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 269442 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 592714 | 0.026 |
8 | 1513341 | 0.025 |
9 | 1391573 | 0.024 |
3 | 1165217 | 0.023 |
5 | 316454 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 269442 | 1 |
0.029 | 130000 | 1 |
0.030 | 32000 | 1 |
0.031 | 100000 | 1 |
0.032 | 450000 | 3 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online